PMID- 34736163 OWN - NLM STAT- MEDLINE DCOM- 20220301 LR - 20240226 IS - 1532-3072 (Electronic) IS - 0040-8166 (Linking) VI - 73 DP - 2021 Dec TI - MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3beta/beta-catenin signaling pathway. PG - 101672 LID - S0040-8166(21)00188-9 [pii] LID - 10.1016/j.tice.2021.101672 [doi] AB - Apart from the fact that miR-552-3p is known to promote cell progression among various cancers, its function on non-small cell lung cancer (NSCLC) is unknown which therefore emerges as the purpose of this research. TargetScan, Starbase, miRWalk, miRDB and the Cancer Genome Atlas Lung Adenocarcinoma (TCGA-LUAD) were utilized to analyze the target genes of miR-552-3p. NSCLC cells were transfected with miR-552-3p mimic, miR-552-3p inhibitor, Fibulin 5 (FBLN5) overexpression plasmid, and small interfering FBLN5 (siFBLN5) and treated with extracellular regulated protein kinases (ERK) pathway inhibitor PD98059. MiR-552-3p, FBLN5, p-ERK, ERK, p-glycogen synthase kinase 3beta (GSK3beta) and beta-catenin levels were detected through quantitative reverse transcription-polymerase chain reaction and western blot. The binding sites between miR-552-3p and FBLN5 were predicted by TargetScan, which was tested through dual luciferase reporter analysis. Cell viability, migration and invasion were determined by cell counting kit-8 (CCK-8) assay, wound healing assay and transwell assay, respectively. MiR-552-3p expression was upregulated in NSCLC and FBLN5 functioned as its target. MiR-552-3p mimic promoted proliferation, migration, invasion, p-ERK, p-GSK3beta and beta-catenin expressions in NSCLC cells while miR-552-3p inhibitor did the opposite. Overexpressed FBLN5 suppressed proliferation, migration, invasion, p-ERK, p-GSK3beta and beta-catenin expressions in NSCLC cells whereas siFBLN5 exerted the effects opposite to overexpressed FBLN5. PD98059 enhanced the effect of overexpressed FBLN5 on NSCLC cell migration and invasion while reversing the effect of siFBLN5. MiR-552-3p facilitated cell proliferation, migration and invasion in NSCLC through sponging FBLN5 via activation of ERK/GSK3beta/beta-catenin pathway. CI - Copyright (c) 2021 Elsevier Ltd. All rights reserved. FAU - Huang, Mingfang AU - Huang M AD - Thoracic Surgery Department, Hainan General Hospital, China. FAU - Liao, Xuqiang AU - Liao X AD - Thoracic Surgery Department, Hainan General Hospital, China. FAU - Li, Liang AU - Li L AD - Thoracic Surgery Department, Hainan General Hospital, China. FAU - Li, Gao AU - Li G AD - Thoracic Surgery Department, Hainan General Hospital, China. FAU - Chen, Minbiao AU - Chen M AD - Thoracic Surgery Department, Hainan General Hospital, China. Electronic address: chenminbiao_cmb1@163.com. LA - eng PT - Journal Article DEP - 20211029 PL - Scotland TA - Tissue Cell JT - Tissue & cell JID - 0214745 RN - 0 (Extracellular Matrix Proteins) RN - 0 (FBLN5 protein, human) RN - 0 (MIRN552 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (beta Catenin) RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) SB - IM MH - Animals MH - Base Sequence MH - Carcinoma, Non-Small-Cell Lung/*genetics/pathology MH - Cell Line MH - Cell Movement/*genetics MH - Cell Proliferation/genetics MH - Extracellular Matrix Proteins/genetics/*metabolism MH - Extracellular Signal-Regulated MAP Kinases/*metabolism MH - Gene Expression Regulation, Neoplastic MH - Glycogen Synthase Kinase 3 beta/*metabolism MH - Humans MH - Lung Neoplasms/*genetics/pathology MH - Male MH - Mice, Inbred BALB C MH - Mice, Nude MH - MicroRNAs/genetics/*metabolism MH - Neoplasm Invasiveness MH - Signal Transduction MH - Up-Regulation/genetics MH - beta Catenin/*metabolism MH - Mice OTO - NOTNLM OT - Cell proliferation OT - ERK/GSK3beta/beta-catenin OT - Fibulin 5 OT - MiR-552-3p OT - Migration and invasion OT - Non-small cell lung cancer EDAT- 2021/11/05 06:00 MHDA- 2022/03/03 06:00 CRDT- 2021/11/04 20:20 PHST- 2021/04/12 00:00 [received] PHST- 2021/10/09 00:00 [revised] PHST- 2021/10/22 00:00 [accepted] PHST- 2021/11/05 06:00 [pubmed] PHST- 2022/03/03 06:00 [medline] PHST- 2021/11/04 20:20 [entrez] AID - S0040-8166(21)00188-9 [pii] AID - 10.1016/j.tice.2021.101672 [doi] PST - ppublish SO - Tissue Cell. 2021 Dec;73:101672. doi: 10.1016/j.tice.2021.101672. Epub 2021 Oct 29.